Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bioanalysis

Showing results (41-50 of 3,550) with videos related to

Pageof 355
Sort By:
Bioanalysis|November 19, 2010
Unwanted immunogenicity: lessons learned and future challengesMeenu Wadhwa, Robin Thorpe
Bioanalysis|November 19, 2010
Therapeutic monoclonal antibody concentration monitoring: free or total?Bing Kuang, Lindsay King, Huifen Faye Wang
Bioanalysis|November 19, 2010
LC-MS/MS for immunosuppressant therapeutic drug monitoringBenedetta C Sallustio
Bioanalysis|November 19, 2010
Therapeutic drug monitoring in cancer chemotherapyDylan M Bach, Joely A Straseski, William Clarke
Bioanalysis|November 19, 2010
Analytical methodologies utilized in the search for chronic disease biomarkersTuulia Hyötyläinen
Bioanalysis|November 19, 2010
Best practices in a tiered approach to metabolite quantification: views and recommendations of the European Bioanalysis ForumPhilip Timmerman, Morten Anders Kall, Ben Gordon, et al.
Bioanalysis|November 19, 2010
Opinion: Microdosing: safer clinical trials and fewer animal testsGill Langley, Sebastien Farnaud
Bioanalysis|November 19, 2010
Early human ADME using microdoses and microtracers: bioanalytical considerationsStephen R Dueker, Peter N Lohstroh, Jason A Giacomo, et al.
Bioanalysis|November 19, 2010
Analytical validation of accelerator mass spectrometry for pharmaceutical developmentBradly D Keck, Ted Ognibene, John S Vogel
Bioanalysis|November 19, 2010
Microdosing: current and the futureGraham Lappin
Pageof 355

Showing results (41-50 of 3,550) with videos related to

Sort By:
Pageof 355
Bioanalysis|November 19, 2010
Unwanted immunogenicity: lessons learned and future challengesMeenu Wadhwa, Robin Thorpe
Bioanalysis|November 19, 2010
Therapeutic monoclonal antibody concentration monitoring: free or total?Bing Kuang, Lindsay King, Huifen Faye Wang
Bioanalysis|November 19, 2010
LC-MS/MS for immunosuppressant therapeutic drug monitoringBenedetta C Sallustio
Bioanalysis|November 19, 2010
Therapeutic drug monitoring in cancer chemotherapyDylan M Bach, Joely A Straseski, William Clarke
Bioanalysis|November 19, 2010
Analytical methodologies utilized in the search for chronic disease biomarkersTuulia Hyötyläinen
Bioanalysis|November 19, 2010
Best practices in a tiered approach to metabolite quantification: views and recommendations of the European Bioanalysis ForumPhilip Timmerman, Morten Anders Kall, Ben Gordon, et al.
Bioanalysis|November 19, 2010
Opinion: Microdosing: safer clinical trials and fewer animal testsGill Langley, Sebastien Farnaud
Bioanalysis|November 19, 2010
Early human ADME using microdoses and microtracers: bioanalytical considerationsStephen R Dueker, Peter N Lohstroh, Jason A Giacomo, et al.
Bioanalysis|November 19, 2010
Analytical validation of accelerator mass spectrometry for pharmaceutical developmentBradly D Keck, Ted Ognibene, John S Vogel
Bioanalysis|November 19, 2010
Microdosing: current and the futureGraham Lappin
Pageof 355